TCTR20181210002RecruitingUnknown
Validation of visual acuity on tablet application “Chudjane†used in clinical practice in normal eyes population
Faculty of Medicine, Siriraj Hospital0 sites52 target enrollmentStarted: December 10, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Enrollment
- 52
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Years to 0 N/A (No limit) (—)
- Sex
- All
Inclusion Criteria
- •-Heathy volunteers
- •-Age at least 18 years old
- •-No history ocular disease (Except refractive error that can corrected by glasses
- •-Voluteer can read Arabic numeral
Exclusion Criteria
- •Volunteer is
- •Visual acuity are worse than 6/60
- •Cannot co-operate with tester
- •history of topical anesthetic drug or cyclopegic drug
Investigators
Similar Trials
Recruiting
Not Applicable
Evaluation of a tablet visual acuity testH53.0Q13.1Q13.3E70.3H35.1H53.5H50Amblyopia ex anopsiaAbsence of irisCongenital corneal opacityRetinopathy of prematurityAlbinismColour vision deficienciesOther strabismusDRKS00011508niversitätsklinikum Essen50
Recruiting
Not Applicable
Smartphone-based visual acuity assessment in a crossectional study in a university eye clinicAll eye diseasesDRKS00033292niversitätsaugenklinik Kiel100
Not yet recruiting
Not Applicable
Testing the suitability of the Vision Impairment in Low Luminance (VILL) questionnaire for assessing subjective visual function and vision-related quality of life in people with diabetic eye changes and glaucomaCode: E10.30+H36.0Code: E11.30+H36.0H40.1H40.2Primary angle-closure glaucomaPrimary open-angle glaucomaDRKS00033399niversitäts-Augenklinik Bonn340
Completed
Not Applicable
Visual field testing for glaucoma patients using iPad appGlaucomaISRCTN77744218Addenbrooke's Hospital Cambridge University NHS Trust40
Active, not recruiting
Not Applicable
Evaluation of Safety and Efficacy on Visual Acuity Outcome and Choroidal Neovascularization of Intravitreal Somministration of Bevacizumab Avastin, Roche, United Kingdom in patients with Subfoveal Choroidal Neovascularization due to Age Related Macular Degeneration - NDSubfoveal Choroidal Neovascularization due to Age Related Macular Degeneration who did not respond to currently available treatmentsMedDRA version: 6.1Level: PTClassification code 10060823EUCTR2006-002424-42-ITOSPEDALE SACRO CUORE-DON CALABRIA150